INN: Tranexamic acid
Presentation: solution for intravenous administration 50 mg/ml vials 5 ml No.10
The product is on the List of Vital and Essential Drugs.
Registration number: LP-006024
Prescription drug
Pharmacotherapeutic group: hemostatic agents - fibrinolysis inhibitor
Indications for Use:
Prevention and treatment of bleedings caused by generalized or local fibrinolysis in adults and children aged 1 year and older, including:
- menorrhagia and metrorrhagia;
- gastroenterorrhagia;
- bleedings after surgical interventions on prostate gland and urinary tract;
- bleedings during surgical interventions in nasal, mouth and throat cavity (adenoidectomy, tonsillectomy, dental extraction);
- bleeding during thoracic, abdominal and other extensive surgical interventions (including cardiac surgery);
- obstetric-gynecologic bleedings (including bleedings during gynecological surgical interventions);
- bleedings caused by using of fibrinolytic drugs.
Shelf life: 2 years